Signum Biosciences Company
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Boulder, Colorado, United States
Founded Date:
2004
Employees Number:
11-50
Investors Number:
1
Total Funding:
$55M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership